Skip to main content
. 2021 Apr 23;42(9):1486–1497. doi: 10.1038/s41401-021-00657-w

Fig. 6. Triptolide suppresses tumor growth in a xenograft model and lung metastasis of NCI-H1299 cells.

Fig. 6

a, b The antitumor effect of triptolide on the NCI-H1299 xenograft model. Tumor-bearing mice were administered vehicle and triptolide (1.5 and 0.75 mg/kg) every 2 days for a total of 18 days. At the end of the experiment, the mice were sacrificed, and the tumors were harvested. The tumor volume curve and tumor weight are presented in a and b, respectively. c, d The effect of triptolide on the expression of β-catenin and EMT markers in NCI-H1299 xenograft tumors. Immunohistochemical assays were conducted to detect β-catenin, N-cadherin, vimentin, E-cadherin, and ZO-1 expression. Representative images and quantitative data are presented in c and d. The images were taken at ×100 magnification. e, f The effect of triptolide on the lung metastasis of NCI-H1299 cells. After tail vein injections of NCI-H1299 cells, the mice were administered triptolide (1.5 mg/kg) three times per week for a total of 6 weeks. H&E staining of lung sections and quantitative data of metastatic foci are shown in e and f. H&E images were taken at ×100 magnification. TPL triptolide. The data are presented as the mean ± SEM, n = 5 in vehicle group. n = 6 in TPL group.  ***P < 0.001 vs. the vehicle group.